256 related articles for article (PubMed ID: 31883309)
1. An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis.
Xiong Y; Yuan L; Xiong J; Xu H; Luo Y; Wang G; Ju L; Xiao Y; Wang X
J Cell Mol Med; 2020 Feb; 24(3):2342-2355. PubMed ID: 31883309
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
3. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
[TBL] [Abstract][Full Text] [Related]
4. An immune cell infiltration-related gene signature predicts prognosis for bladder cancer.
Chen H; Pan Y; Jin X; Chen G
Sci Rep; 2021 Aug; 11(1):16679. PubMed ID: 34404901
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
6. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
7. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
8. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
Chen F; Wang Q; Zhou Y
BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
[TBL] [Abstract][Full Text] [Related]
9. Construction of prognosis model of bladder cancer based on transcriptome.
Chen Q; Cai L; Liang J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):79-86. PubMed ID: 35462469
[TBL] [Abstract][Full Text] [Related]
10. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
Hereditas; 2019; 156():24. PubMed ID: 31333338
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.
Dai ZT; Xiang Y; Wang Y; Bao LY; Wang J; Li JP; Zhang HM; Lu Z; Ponnambalam S; Liao XH
Aging (Albany NY); 2021 May; 13(10):13876-13897. PubMed ID: 33962392
[TBL] [Abstract][Full Text] [Related]
12. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
Zhang Y; Xie Y; Feng Y; Wang Y; Xu X; Zhu S; Xu F; Feng N
Gene; 2022 Jan; 808():145966. PubMed ID: 34530089
[TBL] [Abstract][Full Text] [Related]
13. A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis.
Wang Y; Yang Z
Cancer Cell Int; 2020; 20():159. PubMed ID: 32425694
[TBL] [Abstract][Full Text] [Related]
14. An EMT-related gene signature for the prognosis of human bladder cancer.
Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
Qu G; Xu Y; Lu Z; Nie H; Tang C; Hou J; Wen X
Oxid Med Cell Longev; 2022; 2022():4754935. PubMed ID: 36211821
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
[TBL] [Abstract][Full Text] [Related]
17. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of a mRNA signature in peripheral T-cell lymphomas: A mRNA expression analysis.
Tu J; Kuang Z; Xie X; Wu S; Wu T; Chen S
J Cell Mol Med; 2021 Jan; 25(1):84-95. PubMed ID: 33259129
[TBL] [Abstract][Full Text] [Related]
19. A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer.
Wang W; Zhang X; Jiang S; Xu P; Chen K; Li K; Wang F; Le X; Zhang K
Front Immunol; 2023; 14():1187286. PubMed ID: 37691944
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
